Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1222.9
(-1.92%)
INR 1222.9
(-1.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 212.35 Million INR | 303.41% |
| 2022 | 52.64 Million INR | -81.79% |
| 2021 | 289.03 Million INR | -20.44% |
| 2020 | 363.29 Million INR | -60.41% |
| 2019 | 917.64 Million INR | 0.0% |
| 2018 | - INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 8.67 Million INR | 0.0% |
| 2023 FY | 212.35 Million INR | 303.41% |
| 2023 Q3 | 345 Million INR | 3875.57% |
| 2023 Q4 | 212.35 Million INR | -38.45% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 52.64 Million INR | -81.79% |
| 2022 Q4 | 52.64 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 207.39 Million INR | 0.0% |
| 2021 Q4 | 289.03 Million INR | 0.0% |
| 2021 FY | 289.03 Million INR | -20.44% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 361.34 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 363.29 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 363.29 Million INR | -60.41% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 559.84 Million INR | 0.0% |
| 2019 Q4 | 917.64 Million INR | 0.0% |
| 2019 FY | 917.64 Million INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| 2018 Q4 | - INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 235.2 Million INR | 9.713% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -1420.304% |
| Sigachi Industries Limited | 265.79 Million INR | 20.106% |
| Bal Pharma Limited | 363.82 Million INR | 41.632% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -90.239% |
| Medico Remedies Limited | 8.67 Million INR | -2348.755% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | 45.099% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -99.208% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 84.865% |
| Shilpa Medicare Limited | 5.6 Billion INR | 96.209% |
| Aarti Drugs Limited | 2.75 Billion INR | 92.287% |
| Lupin Limited | 1.55 Billion INR | 86.324% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 99.005% |
| Zydus Lifesciences Limited | 251 Million INR | 15.396% |
| Windlas Biotech Limited | 20.18 Million INR | -952.309% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 96.755% |
| Valiant Laboratories Limited | 746.63 Million INR | 71.558% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | 10.171% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 79.934% |
| Ipca Laboratories Limited | 5.8 Billion INR | 96.341% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 40.336% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -1496.662% |
| Bajaj HealthCare Limited | 650.34 Million INR | 67.347% |
| RPG Life Sciences Limited | -30.3 Million INR | 800.845% |
| Mankind Pharma Limited | 248.67 Million INR | 14.606% |
| Laurus Labs Limited | 8.6 Billion INR | 97.532% |
| Piramal Pharma Limited | 24.83 Billion INR | 99.145% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 17520.509% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 98.676% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 66.228% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 86.001% |
| Unichem Laboratories Limited | 382.22 Million INR | 44.442% |
| Sequent Scientific Limited | 1.42 Billion INR | 85.121% |
| Novartis India Limited | 50.7 Million INR | -318.848% |
| Wanbury Limited | 820 Million INR | 74.103% |
| Wockhardt Limited | 8.91 Billion INR | 97.617% |
| Themis Medicare Limited | 267.74 Million INR | 20.686% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -181.006% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 99.329% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -43.863% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 96.455% |
| Divi's Laboratories Limited | 20 Million INR | -961.78% |
| NATCO Pharma Limited | 53 Million INR | -300.672% |
| Gufic Biosciences Limited | 1.53 Billion INR | 86.207% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 97.896% |
| Procter & Gamble Health Limited | 68.8 Million INR | -208.657% |
| FDC Limited | 2.46 Million INR | -8511.354% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 88.427% |
| Granules India Limited | 689.71 Million INR | 69.211% |
| Medicamen Biotech Limited | 12.55 Million INR | -1591.406% |
| Alkem Laboratories Limited | 400 Million INR | 46.911% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -662.883% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -5856.69% |
| Megasoft Limited | 1.35 Billion INR | 84.352% |
| ZIM Laboratories Limited | 356 Million INR | 40.35% |
| Strides Pharma Science Limited | 6.71 Billion INR | 96.838% |
| Neuland Laboratories Limited | 449.2 Million INR | 52.726% |
| Morepen Laboratories Limited | 33.64 Million INR | -531.26% |
| Hikal Limited | 4.22 Billion INR | 94.978% |
| Indoco Remedies Limited | 3.51 Billion INR | 93.963% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -52989.0% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -59.019% |
| Hester Biosciences Limited | 1.81 Billion INR | 88.318% |